Abstract: The present disclosure relates to to compositions and methods relating to cytokine agonists and their engineered polypeptides. The engineered polypeptides have specificity to receptors in immune systems including IL-2/15, Type I IFN and IL-10. The present disclosure also relates to methods for identifying surrogate cytokine agonists and to a system for engineering ligands that can compel formation of non-naturally-occurring cytokine receptor heterodimers. The present disclosure also relates to methods and system for identifying surrogate agonists for cell surface receptors including dimeric and trimeric receptors.

Abstract: There is provided a video-based automated detection method for epileptic seizure behavior of an animal. The method includes providing an epileptic seizure detection dataset for an animal, constructing a deep learning framework by applying a transfer learning with a spatial-temporal network (STN) to localize and detect seizure behavior of the animal based on the epileptic seizure detection dataset, and detecting epileptic seizure behavior of the animal from raw video frames based on the deep learning framework.

Abstract: A method for a method of prophylaxis and/or therapy of neurological conditions in a subject in need thereof includes the step of administrating a recombinant AAV vector to the subject. Also disclosed is the use of the a recombinant AAV vector in the manufacture of a medicament of prophylaxis and/or therapy of neurological conditions in a subject in need thereof. The recombinant AAV vector includes: PHP.eB; a sequence for introducing the expression of human M3 muscarinic DREADD receptor coupled to Gq (hM3Dq); and an inhibitory neuron-specific Distal-less homeobox (Dlx) gene enhancer sequence.

Abstract: The present disclosure relates generally to compositions and methods for modulating cell surface receptor signaling by specifically recruiting membrane phosphatases, in cis, to a spatial proximity of a natural killer cell receptor (NKR) molecule. More particularly, the disclosure provides novel multivalent protein-binding molecules that specifically bind NKR and antagonize the NKR-mediated signaling through recruitment of a phosphatase activity to dephosphorylate the intracellular domain of the NKR. Also provided are compositions and methods useful for producing such molecules, as well as methods for the treatment of health conditions associated with the inhibition of signal transduction mediated by NKRs.

Abstract: The present disclosure relates generally to compositions and methods for modulating cell surface receptor signaling by specifically recruiting membrane phosphatases, in cis, to a spatial proximity of a signal regulatory protein ? (SIRP?) molecule. More particularly, the disclosure provides novel multivalent protein-binding molecules that specifically bind SIRP? and antagonize the SIRP?-mediated signaling through recruitment of a phosphatase activity to dephosphorylate the intracellular domain of SIRP?. Also provided are compositions and methods useful for producing such molecules, methods for promoting maturation dendritic cells and for production of vaccine, as well as methods for the prevention and/or treatment of health conditions associated with the inhibition of signal transduction mediated by SIRP? and/or CD47.